MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >

Welcome to the MDS Patient Message Board Post New Thread

Welcome to the MDS Patient Message Board. We hope that you will find this to be a very valuable resource in your journey. We have recently revised the format of our forum to be much more user friendly and pleasing on the eyes. Let us know if you have any problems, or if you have additional suggestions on how we might further improve our site.

Recruiting for MDS Study (Thymoglobulin)

Home Demo forums Patient Message Board Recruiting for MDS Study (Thymoglobulin)

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
  • #18926

    Thought I would pass along this e-mail I received.

    Dear Jack Saffell,

    This is an update from the Bone Marrow Failure Disease Consortium. The following study is currently recruiting participants. This update provides information such as a study summary, eligibility criteria, and a list of participating center locations. If you are interested in participating in this study or you have more questions, please contact the center nearest to you.

    Study Name: 5406 – Mechanism and Response of Thymoglobulin in Patients with Myelodysplastic Syndrome (MDS)

    Study Status: Recruiting

    # Myelodysplastic Syndromes

    Myelodysplastic syndrome (MDS) is a heterogeneous disease that is characterized by abnormal hematopoiesis that ranges from low-grade MDS to more aggressive stages that often progress to acute leukemia. The primary objective of this study is to estimate the overall clinical response rate to Thymoglobulin as therapy in patients diagnosed with (MDS) and to determine whether presence of expanded T cell clones has predictive power for hematological response.

    Participating Centers and Contact Information

    # H. Lee Moffitt Cancer Center and Research Institute (BMFDC) (New)
    Tampa, Florida
    Principal Investigator: Alan List, MD
    Contact Person: Tera Uliano
    Office: 813-745-1706

    # The Penn State Cancer Institute (New)
    Hershey, Pennsylvania
    Principal Investigator: Thomas Loughran, Jr.
    Contact Person: Lynn Ruiz, CPL
    Office: 717-531-7377


    they added another Hospital to this study

    # UCLA Department of Hematology and Oncology (BMFDC) (New)
    Los Angeles, California
    Contact Person: Troy Overfield-Blain
    Office: 310-794-8075


    They just added Cleveland Clinic
    # Cleveland Clinic (BMFDC) (New)
    Cleveland, Ohio
    Contact Person: Susan Sunkle
    Office: 216.445.2119


Viewing 3 posts - 1 through 3 (of 3 total)

Register for an account, or login to post to our message boards. Click here.

  • You must be logged in to reply to this topic.



Search Forums

Review answers to commonly asked questions or get answers to your questions from an MDS expert